PLS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.83559850547499E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.02600000051467E-07 |
Normal-vs-Stage2 |
1.377870E-03 |
Normal-vs-Stage3 |
1.32671651442706E-13 |
Normal-vs-Stage4 |
4.10590450528048E-11 |
Stage1-vs-Stage2 |
8.303000E-01 |
Stage1-vs-Stage3 |
4.191800E-04 |
Stage1-vs-Stage4 |
6.581000E-04 |
Stage2-vs-Stage3 |
1.215160E-01 |
Stage2-vs-Stage4 |
8.660100E-02 |
Stage3-vs-Stage4 |
6.541200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.52809986886382E-11 |
Normal-vs-AfricanAmerican |
3.48030000041355E-07 |
Normal-vs-Asian |
9.363600E-01 |
Caucasian-vs-AfricanAmerican |
8.078600E-01 |
Caucasian-vs-Asian |
2.615600E-01 |
AfricanAmerican-vs-Asian |
2.507800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.45583545219097E-12 |
Normal-vs-Female |
1.03770000003944E-06 |
Male-vs-Female |
1.138000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.433300E-04 |
Normal-vs-Age(41-60Yrs) |
2.30379999965891E-07 |
Normal-vs-Age(61-80Yrs) |
2.97550872829788E-12 |
Normal-vs-Age(81-100Yrs) |
1.55369999998989E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.176000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.424000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.461000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.886790E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.206100E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.399800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.679000E-03 |
Normal-vs-Grade 2 |
1.98870000001072E-06 |
Normal-vs-Grade 3 |
8.67140004245925E-09 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
7.766600E-01 |
Grade 1-vs-Grade 3 |
8.062000E-01 |
Grade 1-vs-Grade 4 |
1.964140E-04 |
Grade 2-vs-Grade 3 |
2.272200E-01 |
Grade 2-vs-Grade 4 |
2.17914575273426E-12 |
Grade 3-vs-Grade 4 |
4.62139992940536E-10 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.056680E-03 |
Normal-vs-ccB subtype |
1.65523150741365E-12 |
ccA subtype-vs-ccB subtype |
4.3677994554514E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.72499999956588E-07 |
Normal-vs-N1 |
1.230990E-04 |
N0-vs-N1 |
2.825800E-01 |
|
|